17/11/20 -"Our target price goes up by c.6% mainly due to a higher NAV. The remainder comes from fine-tuning our DCF to reflect the prospects of a vaccine and related logistics opportunities."
Pages
49
Language
English
Published on
17/11/20
You may also be interested by these reports :
26/11/25
The FY25 figures came in above the consensus by low-to-mid-single digit percentages but fell slightly short of our estimates. This was largely helped ...
20/11/25
IAG (ADD ; Spain)’s share price has outperformed the sector for a while, with the strong performance earlier this year, reflecting very high ...
19/11/25
Our in-person discussion with Lufthansa’s C-suite and IR provided clearer visibility on the pacing of the turnaround, the timing and magnitude of ...
19/11/25
TAP’s reprivatisation has attracted strong interest from Europe’s three major airline groups. Its dominant Europe-Brazil position and strategic ...